Filter
792
Filtered Results: 792
Text search:
Kumar,
M.
Featured
Recommendations
75
New Publications
194
Language
Document type
No document type
448
Studies & Reports
146
Guidelines
119
Manuals
39
Fact sheets
15
Strategic & Response Plan
14
Training Material
7
Situation Updates
2
Resource Platforms
2
Countries / Regions
India
139
Nepal
38
Global
34
Indonesia
27
Bangladesh
26
Asia
11
Western and Central Europe
10
Brazil
10
Kenya
9
Russia
9
Germany
7
South–East Asia Region
6
Ghana
5
Nigeria
5
Africa
5
South Africa
5
Eastern Europe
5
Colombia
4
Mozambique
4
Tanzania
4
Middle East and North Africa
4
East and Southern Africa
4
Zambia
4
Thailand
3
Ukraine
3
Lesotho
3
Sierra Leone
3
Afghanistan
3
Malawi
3
Latin America and the Carribbean
3
West and Central Africa
3
Eastern Europe and Central Asia
3
Sri Lanka
3
Liberia
3
Ecuador
3
Myanmar / Burma
3
Timor Leste/ East Timor
2
Benin
2
Cameroon
2
Syria
2
Guinea
2
USA
2
Cambodia
2
Guinea-Bissau
2
Venezuela
2
Western Pacific Region
2
Uganda
2
Yemen
2
Ethiopia
2
Angola
2
South Sudan
2
Tajikistan
1
North Korea
1
Togo
1
China
1
Rwanda
1
Iran
1
Estonia
1
Burkina Faso
1
Zimbabwe
1
Philippines
1
Jordan
1
North America
1
Argentina
1
Lebanon
1
Namibia
1
Sudan
1
Bhutan
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
309
Clinical Guidelines
83
Public Health
56
Women & Child Health
35
Key Resources
27
Capacity Building
6
Pharmacy & Technologies
5
Toolboxes
TB
97
COVID-19
76
Mental Health
51
NTDs
35
HIV
34
Disability
30
Caregiver
27
Planetary Health
27
Rapid Response
16
AMR
16
NCDs
15
Refugee
13
Health Financing Toolbox
11
Natural Hazards
8
Pharmacy
8
Polio
7
Global Health Education
7
Ebola & Marburg
6
Malaria
5
Conflict
3
Specific Hazards
1
Cholera
1
Social Ethics
1
Zika
1
Rappart sur les populations clés.
Historically, the discovery of the sulfa drugs in the 1930s and the subsequent development of penicillin during World War II ushered in a new era in the treatment of infectious diseases. Infections that were common causes of death and disease in the pre-...
Driving progress towards rabies elimination: Results of Gavi’s Learning Agenda on rabies and new WHO position on rabies immunization
To better adapt current case management practices and address excess mortality in otherwise treatable
cases will require better knowledge of the demographic characteristics of the patients and comorbidities
which can make severe dehydration harder to tolerate physiologically. With this in mind, a ...
BUKO Pharma-Kampagne has investigated the causes and consequences of antibiotic resistance in India, South Africa, Tanzania and Germany. Together with our partners we collected data and did interviews with numerous stakeholders. The outcome is presented in a brochure that is now available in English...
A quick reference guide for health authorities and health-care workers
Revised 2015
Orientations provisoires 19 juillet 2021
Addressing comorbidities and risk factors for tuberculosis (TB) is a crucial component of the World Health Organization (WHO)’s End TB Strategy. This WHO operational handbook on tuberculosis. Module 6: tuberculosis and comorbidities aims to support countries in scaling up people-centred care, ...
The WHO standard: Universal access to rapid tuberculosis diagnostics sets benchmarks to achieve universal access to WHO-recommended rapid diagnostics (WRDs), increase bacteriologically confirmed tuberculosis and drug resistance detection, and reduce the time to diagnosis. WHO-recommended rapid diagn...
First published in 2020, this toolkit is intended for clinicians working in acute care, managing adult and paediatric patients with acute respiratory infection, including severe pneumonia, acute respiratory distress syndrome, sepsis and septic shock. The main objective is to provide key tools for us...
- Pacific Possible Background Paper No.6
Joining efforts to control two trelated global epidemics.
Patients with retreatment tuberculosis (TB) represent those
who have been treated previously for onemonth ormorewith
anti-TB drugs and who have been diagnosed once again with
the disease.These patientsmainly include relapses, treatment
after failure, or loss to follow-up on a first-line treatmen...
BMC International Health and Human Rights 2012, 12 :12
http://www.biomedcentral.com/1472-698X/12/12
AN ANALYSIS OF UNICEF MICS 3 SURVEY DATA FROM BANGLADESH, LAO PDR, MONGOLIA AND THAILAND
India contributes to 16% of the global maternal deaths and around 27% of global newborn deaths. Reducing the burden of maternal and newborn mortality and morbidity in urban poor settings today requires an expansion of effective Maternal and Newborn Health (MNH) care services and lowering the barrier...
The primary audience for the guideline is health programme managers, including governmental and non-governmental organizations, and policy makers who are responsible for designing maternal, newborn and child health programmes, primarily in low-income settings. The guideline is also aimed at health p...
